Indoximod as an Active IDO Pathway Inhibitor in Melanoma

May 11, 2017
Yousef Zakharia, MD

Yousef Zakharia, MD, assistant professor, University of Iowa, Holden Comprehensive Cancer Center, discusses indoximod as an active IDO inhibitor in advanced melanoma.